Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianyang Yuyin Granules for early renal damage in elderly hypertension
ChiCTR2100048517Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of qianyangyuyin in nephrosclerosis and hypertension (HTN) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Young's modulus. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
qianyangyuyin
03
Conditions
nephrosclerosishypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2100048517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048517.